← Open Payments lookup

JONATHAN HENZEL: Open Payments

NPI 1114597721 · POST FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,502 in 75 payments from 15 companies in 2025. Trend: 2023 $124 · 2024 $833 · 2025 $1,502

Food & beverage: $1,502
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)17$262
Otsuka America Pharmaceutical, Inc.13$197
Janssen Pharmaceuticals, Inc5$176
Teva Pharmaceuticals USA, Inc.7$165
Axsome Therapeutics, Inc.8$156
Alkermes, Inc.5$105
Lundbeck LLC4$84
Supernus Pharmaceuticals, Inc.2$80
Vanda Pharmaceuticals Inc.3$60
Neurocrine BioSciences, Inc.3$58

Products named: REXULTI, CAPLYTA, INVEGA SUSTENNA, AUSTEDO XR, Sunosi, LYBALVI, Qelbree, Auvelity.

Industry payments across ID — which companies pay providers there.